TripleBlind Lands $24 Million in Series A Funding Led by General Catalyst and Mayo Clinic, in an Oversubscribed Round

Comments are closed.

Eye-Interaction Pioneer Eyefluence Announces Company Launch, Series B Funding
Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders
Strateos Closes $56 Million Series B Financing to Accelerate SmartLab Platform
Cerevance expands financing bringing the total Series B financing to $116 million